Cellular abnormalities in depression: Evidence from postmortem brain tissue

Dialogues in Clinical Neuroscience

Volumn 6, Issue 2, 2004, Pages 185-197

  Stockmeier, Craig A ^a,b   Rajkowska, Grazyna ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Glia; Major depression; Neuron; Neuropathology; Postmortem brain

Indexed keywords

AMYGDALOID NUCLEUS; ARTICLE; AUTOPSY; BRAIN REGION; CELL DAMAGE; CELL DENSITY; CELL SIZE; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CINGULATE GYRUS; CONTROLLED STUDY; DEPRESSION; GLIA; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MEDICAL RESEARCH; MICROSCOPY; MOOD DISORDER; NERVE CELL; NEUROIMAGING; ORBITAL CORTEX; PATHOPHYSIOLOGY; PREFRONTAL CORTEX;

EID: 3042773838     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (94)

1. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 1998;95:13290-13295.
2. Bouras C, Kovari E, Hof PR, et al. Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol (Berl). 2001;102:373-379.
3. Cotter D, Mackay D, Chana G, et al. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex. 2002;12:386-394.
4. Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry. 2001;49:741-752.
5. Rajkowska G, Miguel-Hidalgo JJ, Wei J, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry. 1999;45:1085-1098.
6. Benes FM, Vincent SL, Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry. 2001;50:395-406.
7. Cotter D, Landau S, Beasley C, et al. The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol Psychiatry 2002;51:377-386.
8. Cotter D, Mackay D, Landau S, et al. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry. 2001;58:545-553.
9. Reynolds GP, Zhang ZJ, Patten I, et al. Selective deficits of frontal cortical GABAergic neuronal subtypes defined by calcium binding proteins in psychotic illness. Schizophr Res. 2000;41:255.
10. Rajkowska G, O'Dwyer G, Shao Q, et al. Calbindin immunoreactive nonpyramidal neurons are reduced in the dorsolateral prefrontal cortex in major depression and schizophrenia. Society for Neuroscience, 32nd Annual Meeting, Orlando, Fla. Program No. 497.20. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience; 2002. Available at http://sfn.scholarone.com/itin2002/. Accessed 5 May 2004.
11. Sanacora G, Mason GF, Krystal JH. Impairment of GABAergic transmission in depression: new insights from neuroimaging studies. Crit Rev Neurobiol. 2000;14:23-45.
12. Chana G, Landau S, Beasley C, et al. Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiatry. 2003;53:1086-1098.
13. Honer WG, Falkai P, Chen C, et al. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience. 1999;91:1247-1255.
14. Eastwood SL, Harrison PJ. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull. 2001;55:569-578.
15. Cotter DR, Pariante CM, Rajkowska G. Glial pathology in major psychiatric disorders. In: Agam G, Everall IP, Belmaker RH, eds. The Postmortem Brain in Psychiatric Research. Boston, Mass: Kluwer Academic Publishers; 2002:49-73.
16. Hansson E, Muyderman H, Leonova J, et al. Astroglia and glutamate in physiology and pathology: aspects on glutamate transport, glutamate-induced cell swelling and gap-junction communication. Neurochem Int. 2000;37:317-329.
17. Bowley MP, Drevets WC, Ongur D, et al. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry. 2002;52:404-412.
18. Duman RS, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry. 1999;46:1181-1191.
19. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A. 1996;93:3908-3913.
20. Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry. 1998;172:527-532.
21. Sheline YI, Sanghavi M, Mintun MA, et al. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci. 1999;19:5034-5043.
22. Bremner JD, Narayan M, Anderson ER, et al. Hippocampal volume reduction in major depression. Am J Psychiatry. 2000;157:115-118.
23. Mervaala E, Fohr J, Kononen M, et al. Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol Med. 2000;30:117-125.
24. Steffens DC, Byrum CE, McQuoid DR, et al. Hippocampal volume in geriatric depression. Biol Psychiatry. 2000;48:301-309.
25. Frodl T, Meisenzahl EM, Zetzsche T, et al. Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry. 2002;159:1112-1118.
26. MacQueen GM, Campbell S, McEwen BS, et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A. 2003;100:1387-1392.
27. Vakili K, Pillay SS, Lafer B, et al. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol Psychiatry. 2000;47:1087-1090.
28. Rusch BD, Abercrombie HC, Oakes TR, Schaefer SM, Davidson RJ. Hippocampal morphometry in depressed patients and control subjects: relations to anxiety symptoms. Biol Psychiatry. 2001;50:960-964.
29. Posener JA, Wang L, Price JL, et al. High-dimensional mapping of the hippocampus in depression. Am J Psychiatry. 2003;160:83-89.
30. Lucassen PJ, Muller MB, Holsboer F, et al. Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am J Pathol. 2001;158:453-468.
31. Müller MB, Lucassen PJ, Yassouridis A, et al. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci. 2001;14:1603-1612.
32. Benes FM, Kwok EW, Vincent SL, et al. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry. 1998;44:88-97.
33. Fatemi SH, Earle JA, McMenomy T. Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry. 2000;56:654-663.
34. Beckmann H, Jakob H. Prenatal disturbances of nerve cell migration in the entorhinal region: a common vulnerability factor in functional psychoses? J Neural Transm. 1991;84:155-164.
35. Bernstein HG, Krell D, Baumann B, et al. Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia. Schizophr Res. 1998;33:125-132.
36. Stockmeier CA, Mahajan GJ, Konick L, et al. Neural and glial density is increased and neural soma size is decreased in hippocampus in major depressive disorder. Biol Psychiatry. 2003;53(suppl 8):198.
37. Rosoklija G, Toomayan G, Ellis SP, et al. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry. 2000;57:349-356.
38. Harrison PJ, Eastwood SL. Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus. 2001;11:508-519.
39. Chen B, Dowlatshahi D, MacQueen GM, et al. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry. 2001;50:260-265.
40. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry. 2003;60:804-815.
41. Mayberg HS, Brannan SK, Tekell JL, et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry. 2000;48:830-843.
42. Kennedy SH, Evans KR, Kruger S, et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry. 2001;158:899-905.
43. Mayberg HS, Silva JA, Brannan SK, et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry. 2002;159:728-737.
44. Purba JS, Hoogendijk WJ, Hofman MA, et al. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry. 1996;53:137-143.
45. Raadsheer FC, Hoogendijk WJ, Stam FC, et al. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 1994;60:436-444.
46. Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, et al. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry. 1995;152:1372-1376.
47. Swaab DF, Hofman MA, Lucassen PJ, et al. Functional neuroanatomy and neuropathology of the human hypothalamus. Anat Embryol (Berl). 1993;187:317-330.
48. Holsboer F, Spengler D, Heuser I. The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog Brain Res. 1992;93:385-417.
49. Bernstein HG, Stanarius A, Baumann B, et al. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience. 1998;83:867-875.
50. Underwood MD, Khaibulina AA, Ellis SP, et al. Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims. Biol Psychiatry. 1999;46:473-483.
51. Arango V, Underwood MD, Mann JJ. Fewer pigmented locus coeruleus neurons in suicide victims: preliminary results. Biol Psychiatry. 1996;39:112-120.
52. Klimek V, Stockmeier C, Overholser J, et al. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci. 1997;17:8451-8458.
53. Austin MC, Janosky JE, Murphy HA. Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol Psychiatry. 2003;8:324-332.
54. Bissette G, Klimek V, Pan J, Stockmeier C, Ordway G. Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsycho-pharmacology. 2003;28:1328-1335.
55. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res. 1990;85:119-146.
56. Stockmeier CA, Jurjus G. Monoamine receptors in postmortem brain: do postmortem brain studies cloud or clarify our understanding of the affective disorders. In: Agam G, Everall IP, Belmaker RH, eds. The Postmortem Brain in Psychiatric Research. Boston, Mass: Kluwer Academic Publishers; 2002:363.
57. Arango V, Underwoood MD, Gubbi AV, et al. Localized alterations in pre-and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 1995;688:121-133.
58. 11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry. 2000;57:174-180.
59. Austin M, Whitehead R, Edgar C, et al. Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide. Neuroscience. 2002;114:807.
60. Mann JJ, Huang YY, Underwood MD, et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry. 2000;57:729-738.
61. Ordway GA, Widdowson PS, Smith KS, et al. Agonist binding to α2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. J Neurochem. 1994;63:617-624.
62. Zhu M-Y, Klimek V, Dilley GE, et al. Elevated levels of tyrosine hydroxylase in the locus coerleus in major depression. Biol Psychiatry. 1999;46;1275-1286.
63. Stockmeier CA, Shapiro LA, Dilley GE, et al. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression- postmortem evidence for decreased serotonin activity. J Neurosci. 1998;18:7394-7401.
64. Klimek V, Schenck JE, Han H, et al. Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study. Biol Psychiatry. 2002;52:740-748.
65. Auer DP, Putz B, Kraft E, et al. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 2000;47:305-313.
66. Krystal JH, Sanacora G, Blumberg H, et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry. 2002;7:S71-S80.
67. Nowak G, Ordway GA, Paul IA. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res. 1995;675:157-164.
68. Miguel-Hidalgo JJ, Baucom C, Dilley G, et al. Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol Psychiatry. 2000;48:861-873.
69. Si X, Miguel-Hidalgo JJ, Rajkowska G. GFAP expression is reduced in the dorsolateral prefrontal cortex in depression. Society for Neuroscience, 33rd Annual Meeting, New Orleans, La. Program No. 640.8. 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2003. Online. Available at http://sfn.scholarone.com/itin2003/. Accessed 5 May 2004.
70. Heun R, Kockler M, Papassotiropoulos A. Distinction of early- and late-onset depression in the elderly by their lifetime symptomatology. Int J Geriatr Psychiatry. 2000;15:1138-1142.
71. Krishnan K, Hays J, Tupler L, et al. Clinical and phenomenological comparisons of late-onset and early-onset depression. Am J Psychiatry. 1995; 152:785-788.
72. Lavretsky H, Lesser IM, Wohl M, et al. Relationship of age, age at onset, and sex to depression in older adults. Am J Geriatr Psychiatry. 1998;6:248-256.
73. Johnston-Wilson NL, Sims CD, Hofmann JP, et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry. 2000;5:142-149.
74. Orlovskaya DD, Vostrikov VM, Rachmanova NA, et al. Decreased numerical density of oligodendroglial cells in postmortem prefrontal cortex in schizophrenia, bipolar affective disorder and major depression. Schizophr Res. 2000;41:105.
75. Uranova N, Orlovskaya D, Vikhreva O, et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull. 2001;55:597-610.
76. Tkachev D, Mimmack ML, Ryan MM, et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003;362:798-805.
77. Chen G, Rajkowska G, Du F, et al. Enhancement of hippocampal neurogenesis by lithium. J Neurochem. 2000;75:1729-1734.
78. Malberg JE, Eisch AJ, Nestler EJ, et al. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci. 2000;20:9104-9110.
79. Rocha E, Achaval M, Santos P, et al. Lithium treatment causes gliosis and modifies the morphology of hippocampal astrocytes in rats. Neuroreport. 1998;9:3971-3974.
80. Rocha E, Rodnight R. Chronic administration of lithium chloride increases immunodetectable glial fibrillary acidic protein in the rat hippocampus. J Neurochem. 1994;63:1582-1584.
81. Levine S, Saltzman A, Klein AW. Proliferation of glial cells in vivo induced in the neural lobe of the rat pituitary by lithium. Cell Prolif. 2000;33:203-207.
82. Rajkowska G, Goldman-Rakic PS. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46. Cereb Cortex. 1995;4:323-327.
83. Uylings HB, Sanz-Arigita E, de Vos K, et al. The importance of a human 3D database and atlas for studies of prefrontal and thalamic functions. Prog Brain Res. 2000;126:357-368.
84. Drevets W, Price J, Simpson JR Jr, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997;386:824-827.
85. Miguel-Hidalgo JJ, Rajkowska G. Morphological brain changes in depression: can antidepressants reverse them? CNS Drugs. 2002;16:361-372.
86. Soares J, Mann J. The anatomy of mood disorders-review of structural neuroimaging studies. Biol Psychiatry. 1997;41:36-106.
87. Elkis H, Friedman L, Wise A, et al. Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Arch Gen Psychiatry. 1995;52:735-746.
88. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry. 2000;48:813-829.
89. Bertolino A, Frye M, Callicott JH, et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder. Biol Psychiatry. 1999;45:135S.
90. Winsberg ME, Sachs N, Tate DL, et al. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry. 2000;47:475-481.
91. Moore GJ, Bebchuk JM, Hasanat K, et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry. 2000;48:1-8.
92. Czeh B, Michaelis T, Watanabe T, et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci U S A. 2001;98:12796-12801.
93. Evans S, Akil H, Choudary P, et al. Microarray studies in mood disorders: distinct patterns seen between major depression and bipolar disorder in two frontal cortical regions. ACNP 41st Annual Meeting. December 8-12, 2002. San Juan, Puerto. Scientific Abstract 36; 2002.
94. Tomita H, Vawter M, Evans S, et al. Gene expression profiles in postmortem brains of mood disorder patients. Society for Neuroscience, 33rd Annual Meeting, New Orleans, La. Program No. 640.19.2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2003. Online, 2003. Available at http://sfn.scholarone.com/itin2003/ Accessed 5 May 2004.